FDA Approved: FOSAPREPITANT — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved fosaprepitant as an intravenous antiemetic based on the original NDA submitted by Actavis Pharma, Inc. for prevention of chemotherapy-induced n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

ORIG AP for FOSAPREPITANT (FOSAPREPITANT)